What we do Goldline Pharmaceutical Ltd markets pharmaceutical products under multiple brands through contracted third-party manufacturers, ensuring extensive supply chain and distribution partnerships in India. |
Founded in 2,004 |
Market share - |
Problem solved Provides reliable access to diversified pharmaceutical products by leveraging third-party manufacturing and a robust supply chain partnership model. |
Top clients or who we serve Hospitals, healthcare partners, distributors; operates primarily in B2B pharmaceutical marketing and supply chain management. |
Key management - |
Our journey and innovations Incorporated in 2004, went public in 2013, expanded brand portfolio and contractual manufacturing setup; planning an IPO with fresh equity issuance. |
Where we operate India, through 15 manufacturers and 7 distributors ensuring nationwide presence. |
Top products or what we offer Pharmaceutical products under Goldline Pharma, Cardinal, Aayushman, InLife, and Valiente brands. |
Top brands Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, Goldline Valiente |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Primarily recurring revenue from ongoing pharmaceutical product sales and supply contracts. |
Our industry position - |
Financial highlights Revenue of Rs. 28.06 crore with a net profit of Rs. 2.83 crore for fiscal year ending March 2025. |
Geographical revenue split - |
Order book - |
Whats driving growth Market expansion via strategic contracts with manufacturers and distributors, supported by growing healthcare demand. |
Our future plans Executing Initial Public Offering to raise fresh equity capital for expansion and strengthening supply chain capabilities. |
Our green promise - |
Our people and values - |
Key challenges ahead - |
Interesting facts Operates through promoter group entities managing supply chain and trading operations to ensure seamless distribution. |
Risks and strategy - |
